Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$16.42 -0.10 (-0.61%)
At close: Sep 29, 2026 · 4:00 PM EDT

Aurinia Pharmaceuticals (AUPH) EBT Margin (2019 - 2026)

Updated

Aurinia Pharmaceuticals (AUPH) reported EBT Margin of 58.62% for Q2 2026, up 26.98 percentage points from 31.65% a year earlier and up 2.10 percentage points from the prior quarter.

Analysis

Aurinia Pharmaceuticals (AUPH) EBT Margin (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Aurinia Pharmaceuticals' EBT Margin came in at 51.48%, up 27.46 percentage points year-over-year; for FY2025, it came in at 40.33%, up 37.16 percentage points from FY2024.

  • EBT Margin has increased for four consecutive years, with a five-year change of +245.76 percentage points (FY2020 to FY2025).
  • By year, EBT Margin came in at 3.17% in FY2024 (+47.31 pp), -44.14% in FY2023 (+35.21 pp), -79.35% in FY2022 (+315.80 pp) and -395.15% in FY2021 (-189.72 pp).
  • The Q2 2026 figure ranks as the highest quarterly EBT Margin in data going back to Q4 2019.
  • Year over year, EBT Margin has now increased in each of the last 11 quarters, with an average year-over-year change of +38.12 percentage points over the last eight quarters.
  • The high point for year-over-year EBT Margin in five years was Q3 2021 (a gain of 144985.00 percentage points); the low point was Q4 2021 (a drop of 123.45 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 56.53% (Q1 2026), 46.28% (Q4 2025) and 43.50% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Aurinia Pharmaceuticals 2.20 Bn 623.91 Mn 76.67 Mn 58.62%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 58.62%
Mar 31, 2026 56.53%
Dec 31, 2025 46.28%
Sep 30, 2025 43.50%
Jun 30, 2025 31.65%
Mar 31, 2025 38.98%
Dec 31, 2024 1.96%
Sep 30, 2024 21.85%
Jun 30, 2024 2.58%
Mar 31, 2024 -19.90%
Dec 31, 2023 -58.58%
Sep 30, 2023 -24.12%
Jun 30, 2023 -29.24%
Mar 31, 2023 -74.89%
Dec 31, 2022 -88.59%
Sep 30, 2022 -14.41%
Jun 30, 2022 -125.95%
Mar 31, 2022 -173.97%
Dec 31, 2021 -139.28%
Sep 30, 2021 -342.59%
API Access

Aurinia Pharmaceuticals EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=AUPH&period=max&api_key=YOUR_API_KEY